VemiCo Company

veMico is developing a novel class of gut microbiome therapeutics based on Bifidobacterium spp. derived signalling molecules that play a key role in the regulation of systemic immune function.

Headquarters: Reading, Reading, United Kingdom
Founded Date: 2018
Number Of Exists: 1-10
Industry: Systemic